Correlation Between PhaseRx and MetaStat

Can any of the company-specific risk be diversified away by investing in both PhaseRx and MetaStat at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PhaseRx and MetaStat into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PhaseRx and MetaStat, you can compare the effects of market volatilities on PhaseRx and MetaStat and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PhaseRx with a short position of MetaStat. Check out your portfolio center. Please also check ongoing floating volatility patterns of PhaseRx and MetaStat.

Diversification Opportunities for PhaseRx and MetaStat

0.0

Correlation Coefficient

PhaseRx  MetaStat

Pay attention - limited upside

The 3 months correlation between PhaseRx and MetaStat is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding PhaseRx and MetaStat in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MetaStat and PhaseRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PhaseRx are associated (or correlated) with MetaStat. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MetaStat has no effect on the direction of PhaseRx i.e., PhaseRx and MetaStat go up and down completely randomly.

Pair Corralation between PhaseRx and MetaStat

If you would invest  0.02  in MetaStat on August 2, 2025 and sell it today you would earn a total of  0.01  from holding MetaStat or generate 50.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	95.65%
Values	Daily Returns

PhaseRx  vs.  MetaStat

PhaseRx

Risk-Adjusted Performance

Weakest

Over the last 90 days PhaseRx has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, PhaseRx is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

MetaStat

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in MetaStat are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, MetaStat unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with PhaseRx and MetaStat

The main advantage of trading using opposite PhaseRx and MetaStat positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PhaseRx position performs unexpectedly, MetaStat can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MetaStat will offset losses from the drop in MetaStat's long position.

The idea behind PhaseRx and MetaStat pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.